Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide

By Fujisawa Shinya   Ohno Ryuzo   Shigeno Kazuyuki   Sahara Naohi   Nakamura Satoki   Naito Kensuke   Kobayashi Miki   Shinjo Kaori   Takeshita Akihiro   Suzuki Yoshinari   Hashimoto Hisakuni   Kinoshita Kenji   Shimoya Masahito   Kaise Toshikazu   Ohnishi Kazunori  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 485-493

Springer Publishing Company

Access to resources Recommend Favorite

Retrospective analysis of 119 cases of pediatric acute promyelocytic leukemia: Comparisons of four treatment regimes

By                    

Experimental and Therapeutic Medicine, Vol. 4, Iss. 1, 2012-01 ,pp. : 93-98

Spandidos Publications

Access to resources Recommend Favorite

Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with alltrans retinoic acid and arsenic compoundbased combined therapies

By            

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 177-182

Spandidos Publications

Access to resources Recommend Favorite

Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia

By Au Wing-yan   Lang Brian H.   Fong Bonnie M. W.   Mao Kevin J.   Tam Sidney  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1184-1185

Informa Healthcare

Access to resources Recommend Favorite

Acute promyelocytic leukemia in a young patient with breast cancer

By Kara Ozgur  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 249-250

Humana Press, Inc

Access to resources Recommend Favorite